Inflacam

Active Ingredient:: Meloxicam
Brand:: Inflacam
Origin:: European Union

Inflacam (Meloxicam)

Meloxicam, the active ingredient in Inflacam, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It is indicated for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and other musculoskeletal conditions in adult patients.

GNH India supplies Inflacam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets across Europe, Asia, Africa and the Americas globally.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders.

Osteoarthritis: reduces joint pain, stiffness and swelling, helping to improve mobility and daily activities.
Rheumatoid arthritis: diminishes synovial inflammation, decreasing pain and joint tenderness, and may help limit progressive joint destruction.
Musculoskeletal pain: offers analgesic and anti‑inflammatory effects for acute or chronic pain caused by strains, sprains, overuse injuries or other soft‑tissue conditions.
Post‑operative pain: provides short‑term relief of pain and inflammation following surgical procedures, supporting patient comfort and recovery.

How It Works

Meloxicam exerts its anti‑inflammatory and analgesic actions by reversibly inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2. This inhibition blocks the conversion of arachidonic acid to prostaglandins, which are mediators of inflammation, pain and fever. By preferentially inhibiting COX‑2 at therapeutic doses, meloxicam reduces inflammation while sparing protective gastric prostaglandins to a greater extent than non‑selective NSAIDs.

Side Effects

Like other NSAIDs, meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
Headache: mild to moderate intensity.
Skin rash or itching.

Serious or Rare Side Effects

Peptic ulcer disease or gastrointestinal bleeding.
Hepatotoxicity: elevated liver enzymes or hepatitis.
Severe hypersensitivity reactions: anaphylaxis or Stevens‑Johnson syndrome.

Precautions & Warnings

When prescribing meloxicam, clinicians should consider several safety precautions to minimize risk.

Assess renal function: avoid use in patients with severe renal impairment or monitor closely.
Evaluate cardiovascular risk: use cautiously in individuals with history of heart disease or hypertension.
Monitor hepatic status: discontinue if signs of liver injury appear.
Use lowest effective dose: limit duration to the shortest period necessary for symptom control.
Contraindications: do not prescribe to patients with known hypersensitivity to meloxicam or other NSAIDs.
Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and light.

Avoid Interactions

Meloxicam can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity.
Selective serotonin reuptake inhibitors (SSRIs): elevated bleeding risk.

Moderate Interactions (Monitor Closely)

ACE inhibitors or ARBs: may reduce renal function, especially in dehydrated patients.
Diuretics: potential for reduced effectiveness and kidney injury.
Lithium: NSAIDs can raise lithium serum levels, risking toxicity.

Frequently Asked Questions

Inflacam contains meloxicam, an NSAID that is prescribed to relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis and other musculoskeletal conditions. It helps reduce joint swelling, stiffness and discomfort, improving functional ability in adult patients.

Meloxicam works by reversibly inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin production, it diminishes inflammation, pain and fever while offering a degree of COX‑2 selectivity that may spare gastric prostaglandins compared with non‑selective NSAIDs.

The dosage of Inflacam is determined by the prescribing clinician based on the individual’s condition, severity of symptoms, renal and hepatic function, and other concurrent medications. Healthcare professionals set the appropriate strength, frequency and duration according to current clinical guidelines and patient needs.

The safety of meloxicam in pregnancy and lactation has not been definitively established. It is generally classified as contraindicated during the third trimester because of potential fetal cardiovascular effects, and caution is advised for nursing mothers as the drug may be excreted in breast milk. Consultation with a healthcare provider is essential.

To request Inflacam, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Inflacam (meloxicam) offers once‑daily dosing and a higher COX‑2 selectivity than many traditional NSAIDs such as ibuprofen or naproxen, which may translate into a lower risk of gastrointestinal irritation for some patients. However, it shares similar cardiovascular and renal safety considerations, and the choice of agent should be individualized based on patient risk factors and therapeutic goals.

Inflacam tablets should be stored at ambient temperature, preferably below 25 °C, in their original container to protect them from moisture, light and excessive heat. Keep the product out of reach of children and do not use after the expiry date printed on the packaging.

Inflacam is supplied as oral tablets that are taken by mouth with a full glass of water. The tablet may be swallowed with or without food, although taking it with food can help reduce possible stomach upset. Patients should follow the dosing schedule prescribed by their healthcare professional.

The most serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as myocardial infarction or stroke, and severe renal impairment. Additionally, rare but life‑threatening hypersensitivity reactions like anaphylaxis or Stevens‑Johnson syndrome can occur. Patients should seek immediate medical attention if they experience signs of these conditions.

Inflacam should be avoided in individuals with known hypersensitivity to meloxicam or any other NSAID, in patients with active peptic ulcer disease, severe heart failure, uncontrolled hypertension, or advanced renal or hepatic impairment. It is also contraindicated in the third trimester of pregnancy and should be used with caution in the first two trimesters.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Inflacam (Meloxicam)

Indications & Clinical Uses

How It Works